Listed here are details of current BSGAR audits and links to contribute to the audit.
Also listed are the results of previous BSGAR audits.
OPPORTUNITY. Expression of Interest: opportunity for junior members to get involved with the BSGAR Audit on Imaging in Inflammatory bowel disease
Similar to the process used previously for the recently published Rectal cancer MRI audit, BSGAR are looking for a motivated trainee to work with the committee on the BSGAR multi-centre Inflammatory Bowel Disease audit. We are seeking a keen individual to assist with the data analysis and write-up. Previous experience in audit and manuscript preparation is desirable but not essential. We ask that the trainee can start as soon as possible. Applicants should be BSGAR members. Please submit an application of no more than 200 words to outline your interest and any experience or skills you have that may be relevant to the audit. Deadline for applications 09:00hrs Monday 11th March 2024.
Please forward applications to [email protected].
***********************************
Click here to view the highlights -Survey of rectal cancer MRI technique and reporting tumour descriptors in the UK: a multi-centre BSGAR audit
Percutaneous Liver Biopsy Technique anonymised online survey is being supported by the BSGAR and BSIR. The aim of this survey is to establish the range of practice across the UK. (February 2021)
We would be most grateful if you could complete it by clicking here or by scanning the QR code below.
The current BSGAR audit, National Audit of the Accuracy of Interpretation of Emergency Abdominal CT in Adult Patients Who Present with Non-Traumatic Abdominal Pain, has recently completed. This was a highly successful collaborative audit between the Royal College of Radiologists and BSGAR. Data are currently embargoed as they are under consideration for publication, but will be released once available.
The results of this survey was presented at the BSGAR 2012 annual Meeting at the Hilton Hotel, Cardiff, 1st - 3rd Feb 2012. Please click here to view presentation or scroll to the bottom of the page and click on thumbnail.
February 2009
Accepted for publication in Clin Rad Dec 2011
Aims
To evaluate the variance in current UK clinical practice and clinical outcomes for direct percutaneous radiologically inserted gastrostomy (RIG).
Methods
A prospective UK multi-centre survey of RIG performed between October 2008 and August 2010 was performed through the British Society of GI and Abdominal Radiology(BSGAR).
Results
Data from 684 patients were provided by 45 radiologists working at 17 UK centres. 263 cases (40%) were performed with loop retained catheter, and 346 (53%) with balloon retained devices. 60% of all patients experienced pain in the first 24 hours but settled in the majority thereafter. Early complications, defined as occurring in the first 24 hours, included; minor bleeding (1%), wound infection (3%), peritonism (2%) and tube misplacement (1%). Late complications, defined as occurring between day 2 and day 30 post procedure, included; mild pain (30%), persisting peritonism (2%) and 30 day mortality of 1% (5/665). Pre-procedural antibiotics or anti-MRSA prophylaxis did not affect the rate of wound infection, peritonitis, post procedural pain, or mortality.
93% of cases were performed using gastropexy. Gastropexy decreased post procedural pain (p<0.001), but gastropexy-related complications occurred in 5% of patients. However, post-procedure pain increased with the number of gastropexy sutures used (p<0.001). The use of gastropexy did not affect the overall complication rate or mortality. Post-procedure pain increased significantly as tube size increased (p<0.001). The use of balloon retention feeding tubes was associated with more pain than the deployment of loop retention devices (p<0.001).
Conclusions
RIG is a relatively safe procedure with a mortality of 1%, with or without gastropexy. Pain is the commonest complication . The use of gastropexy, fixation dressing or skin sutures, smaller tube sizes and loop retention catheters significantly reduced the incidence of pain. There was a gastropexy-related complication rate in 5% of patients. Neither pre-procedural antibiotics nor anti-MRSA prophylaxis affected the rate of wound infection.